Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
"Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pharmaceutical preparation of the ANTI-HIV AGENTS elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate that is used in the treatment of HIV INFECTIONS.
| Descriptor ID |
D000069545
|
| MeSH Number(s) |
D02.241.081.251.203.500 D02.705.429.906.250 D02.886.675.182.500 D03.383.129.708.189.500 D03.383.742.680.245.500.600.250 D03.633.100.759.138.881.250 D13.570.230.329.525.250 D13.570.685.245.500.600.250 D26.310.391
|
| Concept/Terms |
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
- Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate
- Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate Drug Combination
- Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Disoproxil Fumarate Drug Combination
- Elvitegravir Cobicistat Emtricitabine Tenofovir Disoproxil Fumarate Drug Combination
|
Below are MeSH descriptors whose meaning is more general than "Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination".
- Chemicals and Drugs [D]
- Organic Chemicals [D02]
- Carboxylic Acids [D02.241]
- Acids, Acyclic [D02.241.081]
- Carbamates [D02.241.081.251]
- Cobicistat [D02.241.081.251.203]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D02.241.081.251.203.500]
- Organophosphorus Compounds [D02.705]
- Organophosphonates [D02.705.429]
- Tenofovir [D02.705.429.906]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D02.705.429.906.250]
- Sulfur Compounds [D02.886]
- Thiazoles [D02.886.675]
- Cobicistat [D02.886.675.182]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D02.886.675.182.500]
- Heterocyclic Compounds [D03]
- Heterocyclic Compounds, 1-Ring [D03.383]
- Azoles [D03.383.129]
- Thiazoles [D03.383.129.708]
- Cobicistat [D03.383.129.708.189]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.129.708.189.500]
- Pyrimidines [D03.383.742]
- Pyrimidine Nucleosides [D03.383.742.680]
- Cytidine [D03.383.742.680.245]
- Deoxycytidine [D03.383.742.680.245.500]
- Emtricitabine [D03.383.742.680.245.500.600]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.383.742.680.245.500.600.250]
- Heterocyclic Compounds, Fused-Ring [D03.633]
- Heterocyclic Compounds, 2-Ring [D03.633.100]
- Purines [D03.633.100.759]
- Adenine [D03.633.100.759.138]
- Tenofovir [D03.633.100.759.138.881]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D03.633.100.759.138.881.250]
- Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Nucleosides [D13.570]
- Deoxyribonucleosides [D13.570.230]
- Deoxycytidine [D13.570.230.329]
- Emtricitabine [D13.570.230.329.525]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D13.570.230.329.525.250]
- Pyrimidine Nucleosides [D13.570.685]
- Cytidine [D13.570.685.245]
- Deoxycytidine [D13.570.685.245.500]
- Emtricitabine [D13.570.685.245.500.600]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D13.570.685.245.500.600.250]
- Pharmaceutical Preparations [D26]
- Drug Combinations [D26.310]
- Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination [D26.310.391]
Below are MeSH descriptors whose meaning is more specific than "Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination".
This graph shows the total number of publications written about "Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" by people in this website by year, and whether "Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination" by people in Profiles.
-
Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: the TAF-IR Study. Antivir Ther. 2018; 23(7):629-632.